Sign inJoin waitlistJoin the waitlist

Kaitlin Batley

Director, Neuromuscular Medicine Fellowship, Pediatric Track · University of Texas Southwestern Medical Center

Credentials: · ·

History

Neuromuscular Medicine, Pediatric Track Fellowship · University of Texas Southwestern Medical Center
Present
University of Texas Southwestern Medical Center
Present
Children's Health Andrews Institute
Present

Neuromuscular Medicine
University of Texas Southwestern Medical Center
2020–2021
Child Neurology
University of Texas Southwestern Medical Center
2017–2020
Pediatrics
University of Texas Southwestern Medical Center
2015–2017
Leonard M. Miller School of Medicine
2011–2015

Research

Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice
JAMA Neurology · 2022 · 74 citations
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial
The Lancet Neurology · 2025 · 17 citations
Access to novel therapies for Duchenne muscular dystrophy-Insights from expert treating physicians
Annals of the Child Neurology Society · 2024 · 2 citations

Susan Iannaccone
5 papers
Jena Krueger
3 papers
Nancy Kuntz
3 papers
Richard Finkel
3 papers
Russell Butterfield
3 papers
Zurisadai Gonzalez-Castillo
3 papers · 3 as a fellow
Aravindhan Veerapandiyan
2 papers
Ashutosh Kumar
2 papers
BD
Basil Darras
2 papers
Craig Zaidman
2 papers
CP
Crystal Proud
2 papers
Susan Matesanz
2 papers

Clinical trials

Nemaline Myopathy Clinical Research Network (NM-CTRN)
Principal investigator · Not yet recruiting
Stanford University
2025–2029
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Site PI · Recruiting
Nationwide Children's Hospital
2025–2028
Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy
Site PI · Available
Santhera Pharmaceuticals